Physician profile
Dean Gmoser
NPI 1316940562
$2,032.61
in general payments reported to CMS, 2019-2025
18 companies · $416 in 2025
The $416 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,162 · 2020: $94.46 · 2022: $117 · 2023: $118 · 2024: $125 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $290.14 | 2019-2020 | |
| Glaxosmithkline, LLC. | $229.56 | 2019-2023 | Bexsero |
| Tris Pharma INC | $180.74 | 2019 | |
| Ironshore Pharmaceuticals INC. | $150.39 | 2019 | |
| Acadia Pharmaceuticals INC | $125.00 | 2024 | Daybue |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2019 | |
| Organon LLC | $124.40 | 2025 | Vtama |
| Ultragenyx Pharmaceutical INC. | $123.59 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $116.99 | 2022 | |
| Sanofi Pasteur INC. | $107.51 | 2025 | |
| Merck Sharp & Dohme LLC | $103.06 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $100.04 | 2025 | |
| Kyowa Kirin, INC. | $84.44 | 2025 | |
| Neos Therapeutics, LP | $76.35 | 2019 | |
| Shire North American Group INC | $39.19 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $25.36 | 2019 | |
| Vertical Pharmaceuticals, LLC | $19.44 | 2019 | |
| Adlon Therapeutics L.P. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Gmoser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.